Table 2. . Features related to time to CNS metastases.
Features | Patients (n) | Brain metastasis at 2 years (%) | p-value |
---|---|---|---|
Age (years): | 0.1044 | ||
– ≤45 | 35 | 40.7 | |
– >45 | 55 | 50.5 | |
Clinical stage: | <0.001 | ||
– I–II | 48 | 72.7 | |
– III | 38 | 31.4 | |
Histological grade: | 0.0011 | ||
– 1–2 | 41 | 56.9 | |
– 3 | 48 | 38.1 | |
Estrogen receptor status: | <0.001 | ||
– Positive | 51 | 70.8 | |
– Negative | 41 | 32.8 | |
HER2 status: | 0.0472 | ||
– Positive | 19 | 38.0 | |
– Negative | 74 | 49.3 | |
Molecular subtype: | <0.001 | ||
– Luminal | 52 | 69.3 | |
– Nonluminal | 38 | 31.9 | |
Molecular subtype: | 0.0002 | ||
– Nontriple negative | 67 | 57.8 | |
– Triple negative | 23 | 29.5 |